Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Genomic complexity and AKT dependence in serous ovarian cancer.

Hanrahan AJ, Schultz N, Westfal ML, Sakr RA, Giri DD, Scarperi S, Janakiraman M, Olvera N, Stevens EV, She QB, Aghajanian C, King TA, Stanchina Ed, Spriggs DR, Heguy A, Taylor BS, Sander C, Rosen N, Levine DA, Solit DB.

Cancer Discov. 2012 Jan;2(1):56-67. doi: 10.1158/2159-8290.CD-11-0170. Erratum in: Cancer Discov. 2012 Apr;2(4):376. Janikariman, Manickam [corrected to Janakiraman, Manickam].

2.

RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.

Stevens EV, Banet N, Onesto C, Plachco A, Alan JK, Nikolaishvili-Feinberg N, Midkiff BR, Kuan PF, Liu J, Miller CR, Vigil D, Graves LM, Der CJ.

Small GTPases. 2011 Jul;2(4):202-210. Epub 2011 Jul 1.

3.

Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth.

Stevens EV, Carpenter AW, Shin JH, Liu J, Der CJ, Schoenfisch MH.

Mol Pharm. 2010 Jun 7;7(3):775-85. doi: 10.1021/mp9002865.

4.

Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I.

Sordet O, Larochelle S, Nicolas E, Stevens EV, Zhang C, Shokat KM, Fisher RP, Pommier Y.

J Mol Biol. 2008 Sep 5;381(3):540-9. doi: 10.1016/j.jmb.2008.06.028. Epub 2008 Jun 17.

5.

Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.

Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, Munson PJ, Weinstein JN, Kohn EC, Pommier Y.

Mol Cancer Ther. 2008 Jan;7(1):10-8. doi: 10.1158/1535-7163.MCT-07-0192. Epub 2008 Jan 9.

6.

Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.

Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B.

Cancer. 2005 Jun 1;103(11):2313-9.

7.

Proteomics in cancer.

Stevens EV, Posadas EM, Davidson B, Kohn EC.

Ann Oncol. 2004;15 Suppl 4:iv167-71. Review. No abstract available.

PMID:
15477302
8.

Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.

Sordet O, Liao Z, Liu H, Antony S, Stevens EV, Kohlhagen G, Fu H, Pommier Y.

J Biol Chem. 2004 Aug 6;279(32):33968-75. Epub 2004 Jun 3.

9.

Proteomic analysis for early detection of ovarian cancer: a realistic approach?

Stevens EV, Liotta LA, Kohn EC.

Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:133-9. Review.

PMID:
14656269
11.

Insulin-dependent production of low-molecular-weight compounds that modify key enzymes in metabolism.

Stevens EV, Husbands DR.

Comp Biochem Physiol B. 1985;81(1):1-8. Review.

PMID:
2861939
12.

Group therapy for bulimic adults.

Stevens EV, Salisbury JD.

Am J Orthopsychiatry. 1984 Jan;54(1):156-161. doi: 10.1111/j.1939-0025.1984.tb01483.x.

PMID:
6584037
13.

Biosynthesis of delta-aminolevulinic acid and porphobilinogen in the domestic fowl (Gallus domesticus).

Stevens EV, Miller LK, Weinstein S, Kappas A.

Comp Biochem Physiol B. 1974 Apr 15;47(4):779-86. No abstract available.

PMID:
4833555

Supplemental Content

Loading ...
Support Center